Skip to main content
Advertisement
Advertisement

HBIO

HBIO logo

Harvard Bioscience Inc

7.92
USD
Sponsored
-0.08
-1.00%
Sep 22, 15:59 UTC -4
Closed
exchange

Pre-Market

7.78

-0.14
-1.82%

HBIO Earnings Reports

Positive Surprise Ratio

HBIO beat 17 of 43 last estimates.

40%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$22.24M
/
-$0.17
Implied change from Q2 26 (Revenue/ EPS)
-2.16%
/
+21.43%
Implied change from Q3 25 (Revenue/ EPS)
+7.99%
/
--

Harvard Bioscience Inc earnings per share and revenue

On Aug 11, 2026, HBIO reported earnings of -0.14 USD per share (EPS) for Q2 26, beating the estimate of -0.21 USD, resulting in a 34.64% surprise. Revenue reached 22.73 million, compared to an expected 21.88 million, with a 3.88% difference. The market reacted with a -4.07% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.17 USD, with revenue projected to reach 22.24 million USD, implying an increase of 21.43% EPS, and decrease of -2.16% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Kewaunee Scientific Corp
Report Date
Sep 09, 2026 For Q1 27
Estimate
-
Actual
$0.57
Surprise
-
FAQ
For Q2 2026, Harvard Bioscience Inc reported EPS of -$0.14, beating estimates by 34.64%, and revenue of $22.73M, 3.88% above expectations.
The stock price moved down -4.07%, changed from $6.39 before the earnings release to $6.13 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on -- analysts, Harvard Bioscience Inc is expected to report EPS of -$0.17 and revenue of $22.24M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement